関連する実験動画
Updated: May 12, 2026

07:31
A Model of Cardiac Remodeling Through Constriction of the Abdominal Aorta in Rats
Published on: December 2, 2016
腎臓高血圧の高齢犬における心室の構造と機能: 実験的な心不全のモデル
Vijaya K Munagala1, Chari Y T Hart, John C Burnett
1Cardiorenal Research Laboratory, Mayo Clinic and Foundation, Rochester, Minn 55905, USA.
Circulation
|February 23, 2005
まとめ
高血圧の高齢犬におけるダイアストリック心不全 (DHF) の新しい大型動物モデルでは,リラックスが低下し,硬さが増加することが示されています. このモデルは,高血圧が多動,線維症,心室機能の変化を引き起こすことを示し,DHFの病理生理学を理解するのに役立ちます.
科学分野:
- 心血管生理学 心血管の生理学
- 病気の動物モデル
- 心不全 病理生理学 心不全 病理生理学
背景:
- 放出分子が保たれているのが特徴であるダイアストリック心不全 (DHF) は,高齢の高血圧患者でよく見られる.
- DHFにおける心室機能の変化の正確なメカニズムについては,議論が続いている.
- DHFの病理生理学を調査するために,臨床的に関連する大型動物モデルが必要です.
研究 の 目的:
- DHFの大型動物モデルを開発し,特徴づけること.
- 慢性高血圧下での老化中の心臓における構造的,機能的変化を解明する.
主な方法:
- 高齢の犬は,慢性高血圧を誘発するために腎臓の包装を施し,実験的なDHF (ExDHF) グループを作成しました.
- 静脈の構造と機能を評価し,若年,高齢の対照群と比較した.
- 鍵となるパラメータには,左心室 (LV) の体積,質量,線維症,リラックス (tau),腹筋硬化,動脈硬化が含まれていました.
主要な成果:
- ExDHFグループは,正常な LV 容量,増加した LV 質量,および心筋線維症を示した.
- コントロールと比較して,ExDHFの犬では,LVのリラックスが有意に低下していた.
- ExDHFの犬では,LVのシストリックおよび動脈の硬さの増加が観察され,腹動脈の硬さの係数は変化しませんでした.
結論:
- 高血圧の高齢の犬は,人間のDHFを模倣して,リラクゼーションが低下したLV高縮と線維症を発症します.
- 静脈動脈のシストリックと動脈の硬さが増加すると,高血圧のエピソード中にリラックスが悪化し,充填圧が上昇する可能性があります.
- この大型動物のモデルは,DHFの病原性に関する貴重な洞察を提供します.
関連する概念動画
Vaccinations
51.1K
Overview
51.1K
Healthcare Associated Infections II: Preventive Measures
3.5K
Essential infection prevention measures are based on the knowledge of the infection chain, the modes of transmission in healthcare settings, and the use of the best practices in all healthcare settings. Compulsory public reporting of healthcare-associated infection rates is needed to allow individuals and the community to make informed choices regarding selecting a healthcare facility.
The best practices for preventing healthcare-associated infections include hand hygiene, patient risk...
The best practices for preventing healthcare-associated infections include hand hygiene, patient risk...
3.5K
Teratogenicity
3.9K
The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
3.9K
Development of Immunocompetence
759
The initiation of cell-mediated immunity can be observed as early as the third month of fetal growth, with active antibody-mediated immunity following approximately one month later.
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...
759
Cancer Vaccines
917
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
917
Mitral Valve Prolapse III: Nursing Management
252
The nursing management of Mitral Valve Prolapse, or MVP, centers around patient education, symptom monitoring, and lifestyle modifications.Patient Education on MVP Diagnosis and Heredity: Nurses should provide comprehensive education about MVP, a condition where the mitral valve does not close appropriately during heartbeats. This education often includes the condition's pathophysiology, symptoms, and potential complications, like arrhythmias or mitral regurgitation. Though not fully...
252

